In the latest quarter, higher costs were felt across the company’s vast health insurance operations.
Related Posts
An Ultrasound Experiment Tackles a Giant Problem in Brain Medicine
There is a problem with the recently approved Alzheimer’s drug, Aduhelm. It can remove some of the amyloid that forms…
Robert F. Kennedy Jr., Foe of Drug Makers and Regulators, Is Poised to Wield New Power
President-elect Donald Trump has encouraged him to “go wild on health” but has not made clear what role Mr. Kennedy…
MAHA Draft Report Brings Relief to Some, Chagrin to Others
A draft of an upcoming White House report on children’s health was not as harsh toward the agriculture industry as…